Alchemedicine, Inc.
PrivateLast Round
Series B
Dec 19, 2022
Total Funding Raised
$19.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alchemedicine, Inc. operates in Healthcare & Life Sciences and is based in Tsukuba. Its latest recorded funding round was a Series B round in December 2022.
Alchemedicine, Inc. is a biotechnology company that specializes in the research and development of small molecule drugs using its proprietary HiSAP medicinal chemistry platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alchemedicine, Inc. Comparables
Compare Alchemedicine, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alivexis, Inc. | 85% | |
| Reborna Biosciences, Inc. | 78% | |
| FIMECS, Inc. | 77% |
For institutional investors. Book with your work email.
Alchemedicine, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 19, 2022 | ||||
| Series A | Feb 16, 2021 | ||||
| Seed | Oct 28, 2019 |
For institutional investors. Book with your work email.
Alchemedicine, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAFCO Group Co., Ltd. | Series B, Series A |
| Mizuho Capital | Series B |
| Joyo Capital Partners | Series B, Series A |
| Beyond Next Ventures | Series B, Series A, Seed |
| Mitsubishi UFJ Capital | Series B, Series A, Seed |
| SMBC Venture Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 69% MoM, reaching 2K.
- Aug 21, 2026
Monthly visitors increased 36% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Alchemedicine, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alchemedicine, Inc.'s valuation, stock price, and market status.
Is Alchemedicine, Inc. a public or private company?
Alchemedicine, Inc. is a private company.
What is the current stock price of Alchemedicine, Inc.?
Alchemedicine, Inc. is a private company, so its shares have no public market price. Caplight tracks Alchemedicine, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alchemedicine, Inc. worth (valuation)?
Valuation information for Alchemedicine, Inc. is not publicly available.
Can I buy Alchemedicine, Inc. stock?
Alchemedicine, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alchemedicine, Inc.'s last funding round?
Alchemedicine, Inc.'s most recent funding round was Series B on December 19, 2022.
Who are the main investors in Alchemedicine, Inc.?
Key investors in Alchemedicine, Inc. include JAFCO Group Co., Ltd., Mizuho Capital, Joyo Capital Partners, Beyond Next Ventures, Mitsubishi UFJ Capital.
Will Alchemedicine, Inc. IPO soon?
No public IPO plans have been announced for Alchemedicine, Inc..
How can I track Alchemedicine, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Alchemedicine, Inc.'s shares on secondary markets.